Orexin A affects ascending contraction depending on downstream cholinergic neurons and descending relaxation through independent pathways in mouse jejunum

Neuropharmacology. 2006 Sep;51(3):466-73. doi: 10.1016/j.neuropharm.2006.04.008. Epub 2006 Jun 8.

Abstract

The involvement of orexin in neural pathways for peristalsis was examined in mouse jejunal segments. Localized distension of the segments using a small balloon resulted in ascending contraction and descending relaxation. Ascending contraction was abolished by atropine and tetrodotoxin. Desensitization to orexin A (OXA) and SB-334867-A, an orexin-1 receptor antagonist, significantly inhibited ascending contraction. Hexamethonium also produced a significant inhibition. Exogenous administration of either OXA or nicotine induced a transient contraction that was completely inhibited by atropine and tetrodotoxin. The OXA-induced contraction was significantly inhibited by hexamethonium and SB-334867-A, whereas the nicotine-induced contraction was not inhibited by SB-334867-A. Descending relaxation was either partially or completely inhibited by l-nitroarginine and tetrodotoxin, respectively. Both SB-334867-A and hexamethonium partially inhibited descending relaxation. A combination of SB-334867-A and hexamethonium had an additive inhibitory effect on descending relaxation. Exogenous OXA, in the presence of atropine, induced a relaxation that was significantly inhibited by both l-nitroarginine and SB-334867-A, but not by hexamethonium. Nicotine in the presence of atropine relaxed the jejunal segment. SB-334867-A, unlike hexamethonium, did not affect nicotine-induced relaxation. These results suggest that OXA plays an important role in the ascending and descending neural reflexes in the mouse jejunum.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / metabolism*
  • Animals
  • Arginine / pharmacology
  • Benzoxazoles / pharmacology
  • Drug Interactions
  • Enzyme Inhibitors / pharmacology
  • Hexamethonium / pharmacology
  • Immunohistochemistry / methods
  • In Vitro Techniques
  • Intracellular Signaling Peptides and Proteins / pharmacology*
  • Jejunum / drug effects*
  • Jejunum / physiology
  • Male
  • Mice
  • Mice, Inbred ICR
  • Models, Biological
  • Muscle Contraction / drug effects*
  • Muscle Contraction / physiology
  • Naphthyridines
  • Neural Pathways / cytology*
  • Neurons* / drug effects
  • Neurons* / metabolism
  • Neurons* / physiology
  • Neuropeptides / pharmacology*
  • Nicotinic Antagonists / pharmacology
  • Nitroarginine / pharmacology
  • Orexins
  • Urea / analogs & derivatives
  • Urea / pharmacology

Substances

  • 1-(2-methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl urea
  • Benzoxazoles
  • Enzyme Inhibitors
  • Intracellular Signaling Peptides and Proteins
  • Naphthyridines
  • Neuropeptides
  • Nicotinic Antagonists
  • Orexins
  • Nitroarginine
  • Hexamethonium
  • Urea
  • Arginine
  • Acetylcholine